Groundbreaking Australian HIV trial should be replicated, researchers say

Trial resulted in 25% fall in new infections in year after rapid rollout of PrEP medication

High-income countries with people at high risk of HIV should replicate a groundbreaking trial in Australia, which has seen new infections fall by 25% in one year following the rapid rollout of free HIV medication, researchers say.

When taken daily the pre-exposure prophylaxis drug known as PrEP is almost 100% effective in preventing HIV-negative people from acquiring the virus. In 2016, NSW became the first Australian state to trial PrEP on a large scale. In the course of just one year 9,714 HIV-negative people at high risk of acquiring HIV were enrolled in the trial, and given PrEP for free. The program was funded by the NSW government.

Continue reading…

Read More Groundbreaking Australian HIV trial should be replicated, researchers say

Related Post